Managing subclinical hypothyroidism

Drug and Therapeutics Bulletin

Volumn 36, Issue 1, 1998, Pages 1-3

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; DRUG SAFETY; FEMALE; FEMALE INFERTILITY; HEART ATRIUM FIBRILLATION; HUMAN; HYPOTHYROIDISM; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OSTEOPOROSIS; SHORT SURVEY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0031965381     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.1998.3611     Document Type: Short Survey

References (17)

1. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985; 145: 1386-8.
2. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol 1991; 34: 77-83.
3. Tunbridge WMG, Evered DC, Hall R et al. The spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol 1977; 7: 481-93.
4. Vanderpump MPJ, Tunbridge WMG, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995; 43: 55-68.
5. Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. JAMA 1987; 258: 209-13.
6. Davies PH, Franklyn JA, Daykm J, Sheppard MC. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine. J Clin Endocrinol Metab 1992; 74: 1189-94.
7. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med 1984; 101: 18-24.
8. Nyström E, Caidahl K, Fager G, Wikkelsö C, Lundberg P-A, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol 1988; 29: 63-76.
9. Tanis BC, Westendorp RGJ, Smelt AHM. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol 1996; 44: 643-9.
10. Alaghband-Zadeh J, Wiseman SA, Greenhalgh RM, Carter GD, Powell JT, Fowler PBS. L-thyroxine reduces serum apolipoprotein b and limits progression of arterial disease in women claudicants with elevated serum thyroid-stimulating hormone. Eur J Intern Med 1992, 3: 213-8.
11. Bearcroft CP, Toms GC, Williams SJ, Noonan K, Monson JP. Thyroxine replacement in post-radioiodine hypothyroidism. Clin Endocrinol 1991; 34. 115-8.
12. Faber J, Galløe AM Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994; 130: 350-6
13. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 1996; 81: 4278-89.
14. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MCK. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol 1992; 37: 500-3.
15. Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M. Bone mineral density in thyroxine treated females with or without previous history of thyrotoxicosis. Clin Endocrinol 1994; 41: 425-32.
16. Sawin CT, Geller A, Wolf PA et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-52.
17. Vanderpump MPJ, Ahlquist JAO, Franklyn JA et al. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 1996; 313: 539-44.